NAD+ replenishment reduces cardiomyocyte senescence and improves diastolic function in the aged male heart
- 30 October 2026
- journal article
- Published by Oxford University Press (OUP) in Cardiovascular Research
Abstract
Aims: Cardiomyocyte senescence is a hallmark of cardiac ageing and closely associated with diastolic dysfunction and heart failure in older adults. Strategies to effectively delay or reverse cardiomyocyte senescence in the aged heart remain limited. We investigated whether NAD+ replenishment regulates cardiomyocyte senescence and cardiac function in ageing. Methods and results: Ventricular NAD+ metabolism, senescence markers, and cardiac function were assessed in young and aged mice of both sexes. Aged male mice exhibited reduced cardiac NAD+ levels due to impaired biosynthesis, limited mitochondrial mobilization, and increased consumption, leading to suppressed SIRT1 and SIRT6 activity and accumulation of senescent cardiomyocytes. These changes were accompanied by diastolic dysfunction, myocardial hypertrophy, and fibrosis. In cultured cardiomyocytes, NAD+ depletion induced cellular senescence, which was reversed by supplementation with the NAD+ precursors nicotinamide riboside (NR) and dihydronicotinamide riboside (NRH). In aged male mice, two months of NR or NRH treatment suppressed senescence markers, improved diastolic function, and reduced hypertrophy and fibrosis. Mechanistically, both NR and NRH activated SIRT1 and suppressed cell cycle arrest markers. NRH induced more robust SIRT1 activation, which deacetylated SIRT6, promoting its binding to histones and enhancing DNA damage repair. In contrast, aged female mice exhibited diastolic dysfunction without significant decline in cardiac NAD+ levels and did not respond to NR or NRH treatment. Conclusion: NAD+ is a critical regulator of cardiomyocyte senescence in ageing male hearts. NAD+ replenishment, particularly with NRH, reverses senescence-associated cardiac dysfunction through coordinated activation of SIRT1 and SIRT6. The sex-specific differences observed highlight distinct mechanisms underlying cardiac ageing and emphasize the importance of considering biological sex in the development of NAD+-based therapeutic strategies.Keywords
Funding Information
- Norges Idrettshøgskole (R01AG066192)
- Norges Idrettshøgskole (R01DK143009)
This publication has 48 references indexed in Scilit:
- NRH, a potent NAD+ enhancer, improves glucose homeostasis and lipid metabolism in diet-induced obese mice through an active adenosine kinase pathwayMetabolism, 2024
- SIRT3 alleviates mitochondrial dysfunction and senescence in diabetes-associated periodontitis by deacetylating LRPPRCFree Radical Biology and Medicine, 2024
- The role of cardiomyocyte senescence in cardiovascular diseases: A molecular biology updateEuropean Journal of Pharmacology, 2024
- The Efficacy of Risk Factor Modification Compared to NAD+ Repletion in Diastolic Heart FailureJACC: Basic To Translational Science, 2024
- Quantitative Analysis of NAD Synthesis-Breakdown FluxesCell Metabolism, 2018
- Trichostatin A inhibits deacetylation of histone H3 and p53 by SIRT6Archives of Biochemistry and Biophysics, 2018
- Short-term administration of Nicotinamide Mononucleotide preserves cardiac mitochondrial homeostasis and prevents heart failureJournal of Molecular and Cellular Cardiology, 2017
- NAD + metabolism: Bioenergetics, signaling and manipulation for therapyBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2016
- Aging-Associated Cardiovascular Changes and Their Relationship to Heart FailureHeart Failure Clinics, 2012
- Cardiac Aging in Mice and Humans: The Role of Mitochondrial Oxidative StressTrends in Cardiovascular Medicine, 2009